Prof. Samir M. Hanash and Prof. Emanuel F. Petricoin highlighted the way proteomics research is changing the way future diagnostic tools will be developed. The pathway specific multiplexed assays, multicentric large cohort studies to validate biomarkers, autoantibody detection against cancer specific antigens are some of the topics that were discussed during these talks. Prof. Hanash stressed on importance of having biological samples from large population over several years so that relevant biomarkers could be identified that will have predictive value before cancer appears. Prof. Petricoin discussed reverse phase protein arrays and their development as diagnostic tools by Theranostics Health.
Overall very interesting talks.